Using Name Lists to Infer Asian Racial/Ethnic Subgroups in the Healthcare Setting

Palo Alto Medical Foundation Research Institute, 795 El Camino Real, Palo Alto, CA 94301, USA.
Medical care (Impact Factor: 2.94). 06/2010; 48(6):540-6. DOI: 10.1097/MLR.0b013e3181d559e9
Source: PubMed

ABSTRACT Many clinical data sources used to assess health disparities lack Asian subgroup information, but do include patient names.
This project validates Asian surname and given name lists for identifying Asian subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese) in clinical records.
We used 205,000 electronic medical records from the Palo Alto Medical Foundation, a multipayer, outpatient healthcare organization in Northern California, containing patient self-identified race/ethnicity information.
Name lists were used to infer racial/ethnic subgroup for patients with self-identified race/ethnicity data. Using self-identification as the "gold standard," sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of classification by name were calculated. Clinical outcomes (obesity and hypertension) were compared for name-identified versus self-identified racial/ethnic groups.
With classification using surname and given name, the overall sensitivities ranged from 0.45 to 0.76 for the 6 racial/ethnic groups when no race data are available, and 0.40 to 0.79 when the broad racial classification of "Asian" is known. Specificities ranged from 0.99 to 1.00. PPV and NPV depended on the prevalence of Asians in the population. The lists performed better for men than women and better for persons aged 65 and older. Clinical outcomes were very similar for name-identified and self-identified racial/ethnic groups.
In a clinical setting with a high prevalence of Asian Americans, name-identified and self-identified racial/ethnic groups had similar clinical characteristics. Asian name lists may be a valid substitute for identifying Asian subgroups when self-identification is unavailable.


Available from: Latha Palaniappan, Jun 04, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hypertension (HTN) is a known major cardiovascular disease risk factor, but prevalence, treatment, and control of HTN among rapidly growing minority groups such as Asian Americans and Hispanics are unknown largely due to either underrepresentation in epidemiologic studies or aggregation of Asian American subgroups.
    American Journal of Hypertension 10/2014; 28(5). DOI:10.1093/ajh/hpu189 · 3.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Studies of racial/ethnic variations in stroke rarely consider the South Asian population, one of the fastest growing sub-groups in the United States. This study compared risk factors for stroke among South Asians with those for whites, African-Americans, and Hispanics. Methods Data on 3290 stroke patients were analyzed to examine risk differences among the four racial/ethnic groups. Data on 3290 patients admitted to a regional stroke center were analyzed to examine risk differences for ischemic stroke (including subtypes of small and large vessel disease) among South Asians, whites, African Americans and Hispanics. Results South Asians were younger and had higher rates of diabetes mellitus, blood pressure, and fasting blood glucose levels than other race/ethnicities. Prevalence of diabetic and antiplatelet medication use, as well as the incidence of small-artery occlusion ischemic stroke was also higher among South Asians. South Asians were almost a decade younger and had comparable socioeconomic levels as whites; however, their stroke risk factors were comparable to that of African Americans and Hispanics. Discussion Observed differences in stroke may be explained by dietary and life style choices of South Asian-Americans, risk factors that are potentially modifiable. Future population and epidemiologic studies should consider growing ethnic minority groups in the examination of the nature, outcome, and medical care profiles of stroke.
    PLoS ONE 09/2014; 9(9):e108901. DOI:10.1371/journal.pone.0108901 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A national strategic framework to address multiple chronic conditions has called for further research on disease trajectories of patients with comorbidities. An observational study using multilevel models to analyze electronic health record data from a multispecialty practice from 2003 to 2010 to examine disease trajectories of patients with at least 2 of 3 common chronic conditions: overweight/obese, hypertension, and depression. Using longitudinal data on up to 110,000 patients, the effects of comorbidities on the probability of having a diagnosis for overweight/obesity or hypertension and on the trajectories of body mass index (BMI) and blood pressure (BP) over time were examined. From 2003 to 2010, the percentage of patients with high BMI receiving an overweight/obesity diagnosis grew from 5.0% to 18.7%, and the percentage of patients with high BP having a hypertension diagnosis rose from 39.9% to 51.7%. The effect of time for patients with high BMI and depression was less than the effect of time for high BMI only patients (P<0.01) in receiving overweight/obesity diagnoses. Co-occurring depression and high BMI was positively associated with BMI trajectory (coefficient=0.06, P<0.01), whereas high BP and high BMI (coefficient=-0.07, P<0.01) or high BP and high BMI and depression (coefficient=-0.05, P<0.01) were negatively associated with BMI trajectories. Although physicians' recording of diagnoses for patients with high BMI and high BP has improved, significant gaps remain. Some co-occurrence patterns of these 3 conditions not only affected the recognition of overweight/obesity and hypertension over time, but also BMI trajectories over time. Quality improvement efforts should target patients with co-occurring depression and overweight/obesity.
    Medical care 03/2014; 52 Suppl 3:S110-7. DOI:10.1097/MLR.0000000000000023 · 2.94 Impact Factor